Other studies have demonstrated that verteporfin, a drug used in photodynamic therapy, can reduce Blood-Brain Barrier (BBB) permeability after stroke by inhibiting the nuclear expression of YAP. This evidence concerns the gene YAP1 and stroke disorder.